CSM
CAMG Solamere Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.61M | Buy |
27,165
+6,363
| +31% | +$376K | 1.32% | 29 |
|
|
2021
Q2 | $1.39M | Sell |
20,802
-139
| -0.7% | -$9.29K | 1.2% | 35 |
|
|
2021
Q1 | $1.32M | Sell |
20,941
-765
| -4% | -$48.3K | 1.14% | 36 |
|
|
2020
Q4 | $1.34M | Sell |
21,706
-10,332
| -32% | -$639K | 1.13% | 32 |
|
|
2020
Q3 | $1.93M | Sell |
32,038
-1,979
| -6% | -$119K | 1.08% | 28 |
|
|
2020
Q2 | $2M | Sell |
34,017
-24,975
| -42% | -$1.47M | 1.1% | 31 |
|
|
2020
Q1 | $3.29M | Sell |
58,992
-23,019
| -28% | -$1.28M | 1.73% | 16 |
|
|
2019
Q4 | $5.27M | Buy |
82,011
+3,576
| +5% | +$230K | 2.43% | 12 |
|
|
2019
Q3 | $3.98M | Sell |
78,435
-7,629
| -9% | -$387K | 1.99% | 18 |
|
|
2019
Q2 | $3.9M | Buy |
86,064
+16,117
| +23% | +$731K | 1.79% | 24 |
|
|
2019
Q1 | $3.34M | Buy |
+69,947
| New | +$3.34M | 1.66% | 30 |
|
|
2018
Q4 | – | Sell |
-5,478
| Closed | -$336K | – | 104 |
|
|
2018
Q3 | $336K | Sell |
5,478
-3,333
| -38% | -$204K | 0.17% | 85 |
|
|
2018
Q2 | $488K | Sell |
8,811
-4,536
| -34% | -$251K | 0.24% | 79 |
|
|
2018
Q1 | $843K | Sell |
13,347
-2,108
| -14% | -$133K | 0.38% | 77 |
|
|
2017
Q4 | $962K | Buy |
15,455
+1,518
| +11% | +$94.5K | 0.43% | 73 |
|
|
2017
Q3 | $885K | Buy |
13,937
+915
| +7% | +$58.1K | 0.44% | 74 |
|
|
2017
Q2 | $730K | Buy |
13,022
+520
| +4% | +$29.2K | 0.42% | 77 |
|
|
2017
Q1 | $682K | Buy |
12,502
+19
| +0.2% | +$1.04K | 0.4% | 81 |
|
|
2016
Q4 | $733K | Buy |
+12,483
| New | +$733K | 0.52% | 70 |
|